The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase II trial of selinexor, an oral selective inhibitor of nuclear export (SINE), in patients with metastatic castration resistant prostate cancer (mCRPC) refractory to abiraterone or enzalutamide.
 
Xiao Wei
No Relationships to Disclose
 
Adam Phillip Siegel
No Relationships to Disclose
 
Rahul Raj Aggarwal
No Relationships to Disclose
 
Amy M. Lin
No Relationships to Disclose
 
Terence W. Friedlander
Honoraria - EMD Serono
Consulting or Advisory Role - Genentech; Pfizer
Speakers' Bureau - Astellas Medivation; Dendreon; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Janssen
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Lawrence Fong
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Oncosec (Inst); Roche/Genentech (Inst)
 
Mirela Paraganlija
No Relationships to Disclose
 
Emily Chang
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - Fortis
Travel, Accommodations, Expenses - Dendreon
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis